echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Infection > Front Immunol: The relationship between COVID-19 vaccine-related thrombosis

    Front Immunol: The relationship between COVID-19 vaccine-related thrombosis

    • Last Update: 2022-01-08
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Introduction: On March 11, 2020, the World Health Organization announced the COVID-19 pandemic
    .


    The pathogen causing this infection, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has a mortality rate of 2.


    Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has a mortality rate of 2.


    Results: In the article about Pfizer and Moderna vaccines, the sample consisted of 3 male patients of uneven age
    .


    The time from vaccination to admission in all cases was ≤3 days.


    Discussion: Vaccine-induced thrombotic thrombocytopenia (VITT) is an unknown etiological phenomenon following vaccination with new coronary pneumonia vaccine
    .


    Several hypotheses have been proposed regarding its physiological and pathological mechanisms


    Table 1 Analysis and research

    Table 1 Analysis and research

    Table 2 Patient Statistics

    Table 2 Patient Statistics

    Figure 1 Patient's medical history

    Figure 1 Patient's medical history

    Table 3 Time of vaccination

    Table 3 Time of vaccination

    Figure 2 Time from vaccination to admission (days)
    .

    Figure 2 Time from vaccination to admission (days)
    .


    Table 4 Symptoms after vaccination

    Table 4 Symptoms after vaccination

    Figure 3 Symptoms after vaccination

    Figure 3 Symptoms after vaccination

    Figure 4 Symptoms and observations on admission

    Figure 4 Symptoms and observations on admission

    Conclusion: Further research is needed to better determine the pathophysiological mechanism of VITT and the genetic, demographic or clinical tendency of high-risk patients, investigate the correlation between VITT and different vaccine types, and test the significance of the research results
    .

    Further research is needed to better determine the pathophysiological mechanism of VITT and the genetic, demographic or clinical tendencies of high-risk patients, investigate the correlation between VITT and different vaccine types, and test the significance of the research results
    .


    Original source:

    Bilotta C, Perrone G, Adelfio V, et al.


    COVID-19 Vaccine-Related Thrombosis: A Systematic Review and Exploratory Analysis.
    Leave a message here
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.